Kopp Investment Advisors’s Exact Sciences EXAS Stock Holding History

Kopp Investment Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,140	Closed	-$131K	–	67
2015 Q4	$131K	Buy	+14,140	New	+$131K	0.06%	64

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Kopp Investment Advisors's EXAS Position: Q1 2016 in Review

Kopp Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2016, closing a stake of 14,140 shares — an estimated $131K sold.

Kopp Investment Advisors first reported a position in EXAS in Q4 2015 and held it in 1 quarter. The position peaked at $131K in Q4 2015. 167 funds tracked by Wall St. Rank hold EXAS as of Q1 2016.

Kopp Investment Advisors reported no remaining Exact Sciences position as of Q1 2016 after selling out during the quarter.
Kopp Investment Advisors sold 14,140 Exact Sciences shares in Q1 2016, an estimated $131K.
Kopp Investment Advisors first reported a position in Exact Sciences in Q4 2015 and held it in 1 quarter.
Kopp Investment Advisors's Exact Sciences position peaked at $131K in Q4 2015.
167 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2016.

Based on Kopp Investment Advisors's 13F filing for Q1 2016, filed 16 May 2016.